Periprocedural Factor Xa Inhibitor Interruption and Resumption for Patients With Atrial Fibrillation Undergoing Dental Procedures
Open Access
- 1 January 2026
- journal article
- Published by XMLink in Korean Circulation Journal
- Vol. 56 (11) , 1064
Abstract
Lee KY, et al. Korean Circ J. 2026 ;56:e82. https://doi.org/10.4070/kcj.2025.0429Keywords
Funding Information
- Samjinpharm (SJ-IIT-24-03)
- National Research Foundation of Korea (IRIS RS-2024-00340590)
- Patient-Centered Clinical Research Coordinating Center (RS-2021-KH119931)
This publication has 16 references indexed in Scilit:
- Perioperative Factor Xa Inhibitor Discontinuation for Patients Undergoing Procedures With Minimal or Low Bleeding RiskJAMA Network Open, 2025
- Perioperative Management of Anticoagulant and Antiplatelet TherapyNEJM Evidence, 2023
- Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulantsJournal of Thrombosis and Haemostasis, 2022
- 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial FibrillationEP Europace, 2021
- Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral AnticoagulantJAMA Internal Medicine, 2019
- Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic riskJournal of Thrombosis and Haemostasis, 2019
- Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysisBMJ, 2017
- Population-based incidence rate of inpatient and outpatient surgical procedures in a high-income countryBritish Journal of Surgery, 2017
- Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgeryJournal of Thrombosis and Haemostasis, 2016
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsThe Lancet, 2014